Study on the antimicrobial effects of Novel Thiazole derivatives by Yılmaz Cankılıç, Meral & Yurttaş, Leyla
654
RESEARCH PAPER
INTRODUCTION
Infectious diseases are one of the most important clinical 
problems in the worldwide. If microorganisms develop 
resistance to drugs that are used continuously, many diseases 
become difficult to control. Thanks to the progress in 
biosynthesis, it is possible to create libraries of molecules and 
some of them may have minor modifications that present 
special value if the molecule is to work as a drug. These new 
molecules may start to produce a different set of possibly 
valuable products that have biological activity. One of these 
molecules, thiazole is a five-membered heterocyclic ring 
which is important fragment of naturally existing molecules 
thiamine (vitamin B1), thiamine pyrophosphate (TPP, a 
coenzyme important in respiration in the Krebs cycle), 
epothilones, carboxylase, and the large family of macrocyclic 
thiopeptide antibiotics, thiostrepton and micrococcin P1. 
Because of its biological importance and easibility of ring 
synthesis, thiazole containing compounds have been widely 
studied (1-3). Their derivatives combined with various 
heterocyclics have been reported with a broad spectrum of 
biological and pharmacological activities such as anaesthetic 
(4, 5), antitubercular (6), antibacterial, antifungal (7-9), 
analgesic (10) anticancer (11) activity, and inhibition of 
acetylcholinesterase activity (12). Therefore much interest 
has been focused on biological activity of thiazole derivatives.
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ABSTRACT
In this work, six 2-[(1/4-methylimidazol/triazol/tetrazol-
2/3/5-yl)thio]-N-(4-substituted thiazol-2-yl) acetamide 
derivatives (2a-f) were synthesized. The antimicrobial activities 
of these substances were examined against some foodborne 
Gram positive and Gram negative test bacteria, Candida albicans, 
Candida glabrata, Candida krusei, and Candida parapsilosis 
yeasts, and some Aspergillus and Penicillium filamentous fungi 
species. The substances were shown considerable antimicrobial 
effect to tested pathogenic microorganisms.
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The purpose of this study was to synthesize of 
2-[(1/4-methylimidazol/triazol/tetrazol-2/3/5-yl)thio]-
N-(4-substituted thiazol-2-yl)acetamide derivatives (2a-
f) by appropriate methods and screening for antimicrobial 
activity for some foodborne pathogenic bacteria, yeasts and 
filamentous fungi.
MATERIALS AND METHODS
Materials
General
All chemicals were purchased from Sigma-Aldrich Chemical 
Co (Sigma-Aldrich Corp., St. Louis, MO, USA) and Merck 
Chemicals (Merck KGaA, Darmstadt, Germany). All melting 
points (m.p.) were determined by MP90 digital melting point 
apparatus (Mettler Toledo, Ohio, USA) and were uncorrected. 
All reactions were monitored by thin-layer chromatography 
(TLC) using Silica Gel 60 F254 TLC plates (Merck KGaA, 
Darmstadt, Germany). Spectroscopic data were recorded 
with the following instruments: IR, Shimadzu Affinity 
1S spectrophotometer (Shimadzu, Tokyo, Japan); NMR, 
Agilent 300 MHz NMR spectrometer (Agilent technologies, 
California, USA), in DMSO-d6, using TMS as internal 
standard; M+1 peaks were determined by Shimadzu 8040 
LC/MS/MS system (Shimadzu, Tokyo, Japan). Elemental 
analyses were performed on a Leco 932 CHNS analyzer 
(Leco, Michigan, USA).
General procedure for the synthesis of 
2-[(1/4-methylimidazol/triazol/tetrazol-2/3/5-yl)thio]-N-
(4-substituted thiazol-2-yl)acetamide derivatives (2a-f)
A mixture of 2-chloro-(4-substituted thiazol-2-yl)acetamide 
(1a, 1b) (2 mmol) and the appropriate thiol derivative (2 
mmol) and K2CO3 (2.4 mol) were stirred in 40 ml of acetone 
at room temperature for 5 h. Acetone was evaporated 
until dryness. The residue was washed with water and 
recrystallized from ethanol to obtain compounds 2a-f (13).
2-[(1-Methyl-1H-imidazol-2-yl)thio]-N-(thiazol-2-yl)
acetamide (2a)
Yield: 75 %. M.p. 159°C.
1H-NMR (300 MHz, DMSO-d6, ppm) δ: 3.59 (3H, s, -CH3), 
3.97 (2H, s, -CH2), 6.94 (1H, s, Ar-H), 7.22 (1H, d, J=3.54 
Hz, Ar-H), 7.25 (1H, s, Ar-H), 7.46 (1H, d, J=3.54 Hz, Ar-H), 
12.47 (1H, s, -NH).
13C-NMR (75 MHz, DMSO-d6, ppm) δ: 33.44, 37.32, 114.17, 
124.12, 129.05, 138.20, 139.70, 158.23, 167.30.
For C9H10N4OS2 calculated: 42.50 % C, 3.96 % H, 22.03 % N, 
found: 42.54 % C, 3.89 % H, 22.08 % N.
HRMS (m/z): [M+H]+ calcd for C9H10N4OS2: 254.33; found 
255.0359.
2-[(4-Methyl-4H-1,2,4-triazol-3-yl)thio]-N-(thiazol-2-yl)
acetamide (2b)
Yield: 71 %. M.p. 212°C.
1H-NMR (300 MHz, DMSO-d6, ppm) δ: 3.59 (3H, s, -CH3), 
4.14 (2H, s, -CH2), 7.23 (1H, d, J=3.54 Hz, Ar-H), 7.48 (1H, 
d, J=3.54 Hz, Ar-H), 8.56 (1H, s, Ar-H), 12.38 (1H, s, -NH).
13C-NMR (75 MHz, DMSO-d6, ppm) δ: 31.28, 36.61, 114.24, 
138.23, 146.79, 148.83, 158.19, 166.59.
For C8H9N5OS2 calculated: 37.64 % C, 3.55 % H, 27.43 % N, 
found: 37.58 % C, 3.59 % H, 27.48 % N.
HRMS (m/z): [M+H]+ calcd for C8H9N5OS2: 255.31; found 
256.0319.
2-[(1-Methyl-1H-tetrazol-5-yl)thio]-N-(thiazol-2-yl)
acetamide (2c)
Yield: 73 %. M.p. 225°C.
1H-NMR (300 MHz, DMSO-d6, ppm) δ: 3.98 (3H, s, -CH3), 
4.36 (2H, s, -CH2), 7.24 (1H, d, J=3.54 Hz, Ar-H), 7.49 (1H, 
d, J=3.54 Hz, Ar-H), 12.47 (1H, s, -NH).
13C-NMR (75 MHz, DMSO-d6, ppm) δ: 34.14, 36.62, 114.34, 
138.24, 153.59, 158.17, 165.87.
For C7H8N6OS2 calculated: 32.80 % C, 3.15 % H, 32.79 % N, 
found: 32.88 % C, 3.17 % H, 32.82 % N.
HRMS (m/z): [M+H]+ calcd for C7H8N6OS2: 256.30; found 
257.0765.
2-[(1-Methyl-1H-imidazol-2-yl)thio]-N-(4-phenylthiazol-
2-yl)acetamide (2d)
Yield: 69 %. M.p. 96°C.
1H-NMR (300 MHz, DMSO-d6, ppm) δ: 3.60 (3H, s, -CH3), 
3.99 (2H, s, -CH2), 7.26-7.35 (2H, m, Ar-H), 7.39-7.45 (3H, 
m, Ar-H), 7.63 (1H, s, Ar-H), 7.89 (2H,d, J=7.17 Hz, Ar-H), 
12.58 (1H, s, -NH).
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13C-NMR (75 MHz, DMSO-d6, ppm) δ: 33.45, 37.38, 108.73, 
124.15, 126.13, 128.30, 129.11, 129.21, 134.65, 139.58, 149.38, 
158.15, 167.59.
For C15H14N4OS2 calculated: 54.53 % C, 4.27 % H, 16.96 % N, 
found: 54.57 % C, 4.29 % H, 16.92 % N.
HRMS (m/z): [M+H]+ calcd for C15H14N4OS2: 330.42; found 
331.0668.
2-[(4-Me thy l-4H -1 ,2 ,4-tr i az ol-3-y l ) thi o]-N - (4-
phenylthiazol-2-yl)acetamide (2e) Yield: 67 %. M.p. 174°C.
1H-NMR (300 MHz, DMSO-d6, ppm) δ: 3.60 (3H, s, -CH3), 
4.16 (2H, s, -CH2), 7.32-7.46 (3H, m, Ar-H), 7.64 (2H, d, 
J=7.17 Hz, Ar-H), 8.56 (1H, s, Ar-H), 12.54 (1H, s, -NH).
13C-NMR (75 MHz, DMSO-d6, ppm) δ: 31.28, 36.65, 108.78, 
126.13, 128.32, 129.22, 134.64, 146.82, 149.41, 158.11, 166.93.
For C14H13N5OS2 calculated: 50.74 % C, 3.95 % H, 21.13 % N, 
found: 50.77 % C, 3.92 % H, 21.18 % N.
HRMS (m/z): [M+H]+ calcd for C14H13N5OS2: 331.41; found 
332.0628.
2-[(1-Methyl-1H-tetrazol-5-yl)thio]-N-(4-phenylthiazol-
2-yl)acetamide (2f)
Yield: 70 %. M.p. 193°C.
1H-NMR (300 MHz, DMSO-d6, ppm) δ: 3.99 (3H, s, -CH3), 
4.39 (2H, s, -CH2), 7.33-7.46 (3H, m, Ar-H), 7.65 (1H, s, Ar-
H), 7.90 (2H, d, J=7.14 Hz, Ar-H), 12.65 (1H, s, -NH).
13C-NMR (75 MHz, DMSO-d6, ppm) δ: 34.16, 36.63, 108.87, 
126.14, 128.34, 129.23, 134.62, 149.45, 153.57, 158.06, 166.19.
For C13H12N6OS2 calculated: 46.97 % C, 3.64 % H, 25.28 % N, 
found: 50.01 % C, 3.67 % H, 22.32 % N.
HRMS (m/z): [M+H]+ calcd for C13H12N6OS2: 332.40; found 
333.0577.
Antimicrobial activity
Microorganisms and media
12 bacteria, 4 yeasts, and 7 filamentous fungi were used as 
test organisms in this study.
Gram positive bacteria: Bacillus cereus ATCC 10876, 
Bacillus subtilis NRRL NRS-744, Enterococcus faecalis 
ATCC 51299, Listeria monocytogenes ATCC 19111 and 
Staphylococcus aureus ATCC 6538. Gram negative bacteria: 
Escherichia coli ATCC 25922, Enterobacter aerogenes 
NRRL B-3567, Klebsiella pneumoniae ATCC 700603, 
Pseudomonas aeruginosa ATCC 27853, Proteus vulgaris 
NRRL B-123, Salmonella typhimurium ATCC 14028, 
and Yersinia enterocolitica Y53 bacteria. Yeasts: Candida 
parapsilosis ATCC 22019, Candida albicans ATCC 90028, 
Candida glabrata ATCC 90030, and Candida krusei ATCC 
6258. Filamentous fungi: Aspergillus niger ATCC 16404, 
Aspergillus flavus ATCC 9807, Aspergillus parasiticus NRRL 
465, Aspe rgillus fumigatus NRRL 113, Penicillium expansum 
ATCC 24692, Penicillium citrinum ATCC 9849, Penicillium 
chryrsogenum ATCC 10106.
Bacteria and yeasts were kept on nutrient agar and yeast 
extract agar plates at 4 °C, respectively. Fungal test cultures 
were subcultured on potato dextrose agar (PDA) for 5-7 d 
at 25 °C.
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Scheme 1. The synthesis protocol of the compounds. Reactants and conditions: i: Et3N, ClCOCH2Cl, THF, 0oC;  
ii: 2/3-Mercapto heterocyclics, K2CO3
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Determination of antimicrobial activity and Minimum 
Inhibitory Concentration (MIC) values of the substances
Determination of antimicrobial activities and MIC values 
of the substances against to test microorganisms were used 
a serial dilution technique using 96-well microtitre plates, 
which has been described by the Clinical and Laboratory 
Standards Institute (14). For this aim, stock solutions of 
the substances were prepared in 20% dimethylsulfoxide 
(DMSO) and two fold dilution series from 4 mg/mL- 7.8125 
µg/mL were prepared using sterile distilled water. 100 μl 
from each of the dilutions was added to 96-well microtiter 
plates. Bacterial and yeast cultures were standardized to 108 
CFU/mL using 0.5 McFarland standard solution. The fungal 
spore suspensions were prepared using sterile 0.1% Tween 
80 and adjusted to about 106 spores/mL. 100 μl of each 
microorganism suspension was then added into the wells 
and incubated at 30-35°C for 24-48 h in aerobic conditions. 
The culture medium alone and medium containing bacteria 
without test compounds were considered as two controls. 
Triplicate wells were applied for each concentration of the 
individual test materials. Chloramphenicol and ketoconazole 
were used as standard antibacterial and antifungal agent, 
respectively. MIC values were detected by using MTT 
method (15-17). A concentration of 5 mg/mL MTT [3-(4, 
5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] 
was prepared in PBS (pH 7.2). 20 µl of MTT solution was 
added to each single well and the 96-well micro-titer plates 
were incubated for 3 h at 30-35 ºC to visually differentiate 
between the live and dead cells. A pink or red color in the 
microdilution well indicated bacterial growth; colorless 
wells were indicative of growth inhibition. The MIC 
was detected as the lowest substance concentration that 
completely inhibited microbial growth.
RESULTS AND DISCUSSION
Chemisty
Six new derivatives were synthesized with a simple, two-pot 
synthesis method as shown in Scheme 1. The structures of 
the compounds were confirmed by spectroscopic technics 
and elemental analysis results. In 1H NMR spectra of the 
compounds, methyl protons were observed at 3.59-3.99 
ppm whereas methylene protons were seen at about 3.97-
4.39 ppm. The proton of nitrogen atom was detected 
at 12.38-12.65 ppm and the other protons were seen at 
aromatic region and between 6.94-8.56 ppm as expected. In 
the 13C NMR spectra of the compounds, methyl, methylene 
and carbonyl carbons were resonated at about 33.50, 37.50 
and 167.30 ppm, respectively. The other carbon atoms were 
resonated at about 108.23-158.23 ppm. In the mass spectra 
of compounds, [M+1] peaks were determined in agreement 
with their molecular formula. Elemental analysis results 
were determined within the theorical values, ±0.4%.
Antimicrobial activity
All the synthesized compounds were screened for in vitro 
antimicrobial activity. The antimicrobial activity was 
evaluated against different bacterial, yeast and filamentous 
fungi strains. Results obtained in the present study relieved 
that all tested substances possess potential antimicrobial 
activity against all the test microorganisms. Results are 
summarized in Table 1. Among the bacteria Bacillus subtilis, 
Enterobacter aerogenes, and Staphylococcus aureus were the 
most resistant species to nearly all compound. In general 
evaluating, it was observed that all of the compounds had 
the activity in 0.25 and 1 mg/mL concentrations as MIC 
value. The lowest MIC values of the substances were found 
to be 0.125 mg/mL against only Yersinia enterocolitica with 
compounds 2e and 2f. There was no direct correlation 
between the effectiveness of the substances to tested 
microorganisms. In addition, the antifungal activity of the 
compounds was examined against four Candida species. 
Compound 2f was found to be more effective against yeasts 
than the others with lower MIC values (Table 1). Otherwise, 
the MIC values obtained were similar for bacteria and yeast 
but higher for filamentous fungi. In antifungal activity 
evaluating for filamentous fungi, all the tested compounds 
inhibited the spore germination against tested fungi.
Among the synthesized compounds, 2a most active 
compound for Aspergillus parasiticus, 2b for Penicillum 
citrinum, 2c for Penicillum expansum, 2d for Penicillum 
citrinum and Penicillum cyrisogenum, 2e for Penicillum 
expansum, 2f for Penicillum expansum and Penicillum 
citrinum with 0.5 mg/mL MIC value when compared to 
others. According to these results, Penicillium species were 
more sensitive than Aspergillus species for the compounds. 
On the other hand, the compounds 2e and 2f (MIC 125 
μg/mL) displayed half the potency of chloramphenicol to 
Yersinia enterocolitica. Other compounds had higher MIC 
values than standards.
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Table 1. Minimum inhibitory concentration (MIC) in µg/mL of all substances and standard antibiotics in µg/mL obtained 
using the microdilution method.
Microorganisms 2a 2b 2c 2d 2e 2f Standards
Bacteria Chloramphenicol
Bacillus cereus 250 250 500 500 500 500 31.25
Bacillus subtilis 500 1000 1000 1000 1000 1000 31.25
Escherichia coli 250 250 250 500 500 500 62.5
Enterococcus faecalis 250 250 250 500 500 500 62.5
Enterobacter aerogenes 1000 500 1000 1000 1000 1000 31.25
Klebsiella pneumoniae 500 250 500 500 1000 1000 62.5
Listeria monocytogenes 250 250 250 500 500 500 125
Pseudomonas aeruginosa 500 250 500 500 500 500 125
Proteus vulgaris 500 250 500 500 500 500 125
Salmonella thyphimurium 500 500 500 500 500 500 125
Staphylococcus aureus 1000 1000 1000 1000 1000 500 125
Yersinia enterocolitica 250 250 250 500 125 125 62.5
Yeasts Ketoconazole
Candida albicans 500 500 500 1000 1000 250 62.5
Candida krusei 500 500 500 1000 1000 250 62.5
Candida parapsilosis 500 500 1000 1000 500 250 62.5
Candida glabrata 500 1000 500 500 500 250 31.25
Filamentous fungi Ketoconazole
Aspergillus flavus 1000 1000 1000 1000 1000 1000 31.25
Aspergillus parasiticus 500 1000 1000 1000 1000 1000 125
Aspergillus niger 1000 1000 1000 1000 1000 1000 62.5
Aspergillus fumigatus 1000 1000 1000 1000 1000 1000 125
Penicillium expansum 1000 1000 500 1000 500 500 125
Penicillium citrinum 1000 500 1000 500 1000 500 125
Penicillium cyrisogenum 1000 1000 1000 500 1000 1000 62.5
CONCLUSION
In conclusion, the objective of the present study was to 
synthesize and evaluate the antimicrobial activities of 
some new thiazole compounds that could be used as 
potent antimicrobial drugs. Six different compounds were 
synthesized newly using 2-aminothiazole derivatives as 
starting materials. It was observed that, the substances had 
bioactivity for the test bacteria in lower concentration than 
fungi. Although the MIC values obtained were higher than 
the standard antibiotics, it is an important result that the 
substances exhibited activity against for bacteria, yeast and 
filamentous fungi. Therefore all compounds were shown 
broad antimicrobial spectrum which have efficiency against 
pathogenic microorganisms associated with various human 
diseases. However, our results clearly revealed that especially 
compounds 2e and 2f exhibited good antimicrobial activity 
to Yersinia enterocolitica bacterium. Also, compound 2b 
exhibited half potency of standard with a MIC value of 125 
µg/mL against Pseudomonas aeruginosa and Proteus vulgaris. 
In addition, bacteria Listeria monocytogenes and Yersinia 
enterocolitica were found as the most susceptible species for 
the tested compounds.
New antimicrobial drug development has global emphasis 
and needs to be supported and established so the resistance of 
microorganisms to antibiotics is a situation that is constantly 
increasing. Because of this reason, we have performed the 
synthesis and investigation of potential, antimicrobial agents, 
in this study.
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Yeni Tiyazol Türevlerinin Sentezi ve Antimikrobiyal 
Aktivitelerinin Araştırılması
ÖZ
Bu çalışmada 2-[(1/4-metilimidazol/triazol/tetrazol-2/3/5-il)
tiyo]-N-(4-sübstitüe tiyazol-2-il) asetamit türevleri (2a-f) 
sentezlenmiştir. Sentezlenen bu maddelerin bazı patojen Gram 
negatif, Gram pozitif bakteriler, Candida albicans, Candida 
glabrata, Candida krusei, ve Candida parapsilosis mayaları ile 
bazı Aspergillus ve Penicillium filamentöz fungus türlerine 
karşı antimikrobiyal aktiviteleri araştırılmıştır. Sentezlenen 
maddelerin test mikroorganizmalarının tümüne karşı önemli 
bir antimikrobiyal aktivitesi olduğu gözlenmiştir.
Anahtar kelimeler: antibakteriyel, antifungal, tiyazol
